SEC Filing Summary: Prana Biotechnology Limited (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Prana Biotechnology Limited, a foreign private issuer based in South Melbourne, Australia, for the month of December 2006. The filing date is December 15, 2006. The registrant files annual reports under Form 20-F. Note: The request metadata references "Alterity Therapeutics Ltd," but the filing text explicitly identifies the registrant as Prana Biotechnology Limited.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notice of a change in interests of a substantial holder and does not contain financial statements or performance metrics.
Material Changes
The primary material change reported is a Notice of Change of Interests of Substantial Holder. Specific details regarding the identity of the holder, the number of shares, or the percentage change are not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the formal notice of the change in substantial holder interests.
Key Facts for Investor Verification
- Verify the specific identity of the substantial holder whose interests changed.
- Confirm the exact number of shares and percentage of ownership involved in the change.
- Check subsequent filings for any financial impact or strategic implications of this ownership change.
- Confirm the current corporate name, as the request metadata (Alterity Therapeutics) differs from the filing registrant (Prana Biotechnology).